Dr. Deligiannidis completed her undergraduate degrees in Biology and Psychology and an Honors Scholars Research Program in Neuroscience and Behavior at the University of Massachusetts at Amherst. As a recipient of NIH pre-doctoral Intramural Research Training Awards, she trained in molecular neuroendocrinology research at the NIH/National Institutes of Child Health and Human Development (NIH/NICHD). Her research was in the neural regulation of melatonin in the pineal gland and chronobiology in mood disorders.

Dr. Deligiannidis completed additional research training at the National Institute of Mental Health (NIMH) and NICHD during medical school and residency. She received her medical degree from the University of Massachusetts Medical School and completed her psychiatry residency and chief residency in psychopharmacology research at UMass Medical School (UMMS)/UMass Memorial Health Care (UMMHC). Dr. Deligiannidis joined faculty at UMMS in October 2009 as an Assistant Professor of Psychiatry. She has Board Certification from the American board of Psychiatry and Neurology.

Dr. Deligiannidis is the Director of the Depression Specialty Clinic, a regional referral center at UMMHC that specializes in the evaluation and treatment of adult patients suffering from major depression, psychotic depression, treatment-resistant depression and bipolar depression. She also is a consultant in the Mood Disorders Comprehensive Consultation Clinic.

Dr. Deligiannidis also evaluates and treats women in the Women’s Mental Health Specialty Clinic at UMMHC. She provides initial evaluations and short-term treatment of women suffering from depression and anxiety during pregnancy or the post-partum period.

Dr. Deligiannidis conducts translational research in the causes of depression in women, with a focus on that which occurs in pregnancy and the postpartum period. She evaluates women enrolled in depression research. Her research interests include:

• Psychoneuroendocrinology (hypothalamic-pituitary-adrenal and gonadal axes, gonadal hormones and neuroactive steroids)
• Neuroimaging and neuroendocrine biomarkers of depression in women during the perinatal period
• Gender differences in depression and treatment response
• Neuroimaging (e.g. MRS, fcMRI, PET)

Dr. Deligiannidis serves on several national and local committees with work focused on research in depression, women’s mental health and psychopharmacology and neuroimaging. She is additionally active in curriculum development and teaching in the areas of psychopharmacology, evidence-based medicine and women’s mental health.

• 2011- National Network of Depression Centers (NNDC), Women’s Mood Disorders Task Force
• 2011- Committee for the Protection of Human Subjects in Research (IRB), University of Massachusetts Medical School, University of Massachusetts Memorial Medical Center
• 2011- American Society of Clinical Psychopharmacology (ASCP), National Model Curriculum Committee
• 2010- Perinatal Psychiatry Genetics Consortium/Postpartum Depression: Action Towards Causes and Treatment (PACT)
• 2010- Medical student applicant interviewer (MD and MD/PhD programs) for Admissions Committee, University of Massachusetts Medical School
• 2010-2013 Women’s Faculty Committee, Office of Faculty Affairs/Diversity and Equal Opportunity Office, University of Massachusetts Medical School, University of Massachusetts Memorial Medical Center
• 2009- University of Massachusetts Medical School, Department of Psychiatry, Adult Psychiatry Residency, Adult Psychiatry/Clinical Investigator Track Residency applicant interviewer
• 2009- Neuroimaging Academic Interest Group at the University of Massachusetts Medical School
• 2009- Reproductive Psychiatry and Women’s Mental Health Academic Interest Group at the University of Massachusetts Medical School
• 2008- American Society of Clinical Psychopharmacology (ASCP) Committee on Residency and Fellowship

Dr. Deligiannidis is an appointed Young Investigator Member of the International Society of Psychoneuroendocrinology (ISPNE) and a member of the Society of Biological Psychiatry (SOBP), the Society of Behavioral Neuroendocrinology (SBE), the Organization for Human Brain Mapping (OHBM), and the American Society of Clinical Psychopharmacology (ASCP). She serves on the Board of Directors of ASCP and on the Trainee Advisory Board for the international journal, Acta Psychiatrica Scandinavica.